Seneca Therapeutics
Seneca Therapeutics is a biotechnology company based in Blue Bell, PA, dedicated to developing revolutionary oncolytic immunotherapeutic candidates for the targeted treatment of solid cancers. With a mission to find a cure for cancer within our lifetime, Seneca Therapeutics works with urgency to turn this promising possibility into a reality.
Driven by a team of experts and supported by academic collaborators and partnerships, Seneca Therapeutics focuses on the development of SVV-001, an oncolytic virus that selectively replicates in tumor cells expressing the TEM8 receptor. Extensively evaluated in preclinical cancer models and clinical trials, their innovative approach shows synergistic anti-tumor effects when combined with immune modulators, cytokines, and checkpoint inhibitors.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.